MARKET INSIGHTS

ZTOX Insights

AI-assisted articles on quarterly results, exchange filings, and earnings calls — tied to the companies you follow.

997 articles published

RENUKA
RENUKA
1 min read
Market Updates Corporate announcement

Shree Renuka Sugars (RENUKA): Company Update

Company Update Execution of definitive agreements for marketing and distribution of sugar under the "Madhur" Brand Execution of definitive agreements for marketing and distribution of sugar under the "Madhur" Brand

Read article
ZYDUSLIFE
ZYDUSLIFE
1 min read
Market Updates Corporate announcement

Zydus Lifesciences (ZYDUSLIFE): Company Update

Company Update Zydus Therapeutics'' New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA. Zydus Therapeutics'' New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA. Zydus Therapeutics'' New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA.

Read article
ECOSMOBLTY
ECOSMOBLTY
1 min read
Market Updates Corporate announcement

ECOS (India) Mobility & Hospitality (ECOSMOBLTY): Board Meeting

Board Meeting 1. Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended March 31, 2026, we submit herewith: a) the Auditor's Report on Standalone & Consolidated Financial Results issued by our Statutory Auditors M/s SS Kothari Mehta & Co. LLP, Chartered Accounts b) Audited Financial Results (Standalone & Consolidated) for the quarter and year ended March 31, 2026 c) Audited Statement of Assets and Liabilities as on March 31, 2026 d)

Read article
ZYDUSLIFE
ZYDUSLIFE
1 min read
Market Updates Corporate announcement

Zydus Lifesciences (ZYDUSLIFE): Press Release

Press Release Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 28, 2026, titled "Zydus Therapeutics New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA". Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 28, 2026, titled "Zydus Therapeutics New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority

Read article
KSHITIJPOL
KSHITIJPOL
1 min read

Kshitij Polyline (KSHITIJPOL): 🚀 Volume Explosion: KSHITIJPOL Breaks 60-Day Average!

💹 Change: ▲ 4.97% 💰 Price: ₹5.70 📊 Volume: 5.89M 🔍 What's happening? Unusual trading activity detected! This could signal a potential breakout or significant news impact. 💡 Pro Tip: Always conduct thorough research before making investment decisions.

Read article
ITIETF
ITIETF
1 min read

ICICI Prudential Nifty IT ETF Sees Unusual Volume Activity

ICICI Prudential Nifty IT ETF (ITIETF) saw heavy trading with 8.47 million shares changing hands, even as the unit price slipped 0.12% to ₹32.59.

Read article
RRSECUR
RRSECUR
1 min read

RR Securities Announces Board Meeting Outcome for Q4 FY26

RR Securities has disclosed the outcome of its board meeting, which approved the audited financial results for the fourth quarter and full year ended 31 March 2026.

Read article
RRSECUR
RRSECUR
1 min read

RR Securities Files Audited Q4 & FY2025-26 Results

RR Securities (RRSECUR) has submitted its audited standalone financial results for the fourth quarter and full year ended March 31, 2026, along with the auditor’s report and declaration.

Read article
RRSECUR
RRSECUR
1 min read

RR Securities Reports Audited Q4 and FY2026 Results

RR Securities (RRSECUR) has released its audited standalone Ind AS financial results for the fourth quarter and full year ended March 31, 2026, along with the auditor's report and declaration.

Read article
WESTLIFE
WESTLIFE
1 min read
Market Updates BSE filings

Westlife Foodworld Announces McDonald's 'Let's Family at McD' Campaign for 30 Years

Westlife Foodworld Limited informs BSE about McDonald's India (W&S) unveiling a new brand campaign 'Let's Family at McD' to celebrate 30 years in India.

Read article
TCS
TCS
1 min read

TCS Leads Midcap Mantra Market Recovery from Lower Levels

TCS featured in Midcap Mantra's market analysis as Indian equities staged a sharp recovery from recent lows, with IT majors drawing renewed investor attention.

Read article
INFOBEAN
INFOBEAN
1 min read
Market Updates BSE filings

Infobeans Technologies Achieves ISO 42001:2023 Certification

Infobeans Technologies Ltd. (INFOBEAN) has achieved ISO 42001:2023 certification, as announced in a BSE filing. The company update is marked positive.

Read article
KLBRENG-B
KLBRENG-B
1 min read

Kilburn Engineering Files Annual Secretarial Compliance Report for FY 2026

Kilburn Engineering has submitted its Annual Secretarial Compliance Report for FY ended March 31, 2026, issued by M/s Nitin S. Sharma & Associates, Practising Company Secretaries.

Read article
Plans built for every investor
TRUSTED BY INVESTORS

Track Indian stocks with ZTOX AI

NSE & BSE filings, quarterly results, insider trades, and smart volume alerts — delivered on WhatsApp or Telegram. No separate app to install.

RK
VJ
SM

"ZTOX alerts helped me catch a multi-bagger stock last quarter. The insider deals notifications are absolutely game-changing for retail investors."

Rahul K., Active Trader
MOST POPULAR
Basic Plan
For active market participants
₹89/mo
Includes:
Track 20 Companies
Insider deals alert
High volume alerts
Start Free
Advanced Plan
For serious investors & traders
₹119/mo
Includes:
Track 50 Companies
All Basic plan features
Block & Preferential Deals
Start Free

No credit card required. Connect WhatsApp or Telegram in minutes.

Secure connection. Your data is always protected.